Lee, Y.-J.; Ahn, S.M.; Hong, S.; Oh, J.S.; Lee, C.-K.; Yoo, B.; Kim, Y.-G.
Association Between Adalimumab Dosing Interval and Uveitis Recurrence in Patients with Ankylosing Spondylitis. Biomedicines 2025, 13, 2089.
https://doi.org/10.3390/biomedicines13092089
AMA Style
Lee Y-J, Ahn SM, Hong S, Oh JS, Lee C-K, Yoo B, Kim Y-G.
Association Between Adalimumab Dosing Interval and Uveitis Recurrence in Patients with Ankylosing Spondylitis. Biomedicines. 2025; 13(9):2089.
https://doi.org/10.3390/biomedicines13092089
Chicago/Turabian Style
Lee, Yeo-Jin, Soo Min Ahn, Seokchan Hong, Ji Seon Oh, Chang-Keun Lee, Bin Yoo, and Yong-Gil Kim.
2025. "Association Between Adalimumab Dosing Interval and Uveitis Recurrence in Patients with Ankylosing Spondylitis" Biomedicines 13, no. 9: 2089.
https://doi.org/10.3390/biomedicines13092089
APA Style
Lee, Y.-J., Ahn, S. M., Hong, S., Oh, J. S., Lee, C.-K., Yoo, B., & Kim, Y.-G.
(2025). Association Between Adalimumab Dosing Interval and Uveitis Recurrence in Patients with Ankylosing Spondylitis. Biomedicines, 13(9), 2089.
https://doi.org/10.3390/biomedicines13092089